Report copyright - HALOZYME THERAPEUTICS, INC.d18rn0p25nwr6d.cloudfront.net/CIK-0001159036/a81af4f0-2b...SAN DIEGO, Jan. 9, 2019 - Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company
Please pass captcha verification before submit form